The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $3,565,780 project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The General Hospital Corporation (Massachusetts General Hospital) to develop a novel high-frequency trans-spinal magnetic stimulation (HF-TSMS) system for the non-invasive treatment of neuropathic back and leg pain. The project aims to refine this HF-TSMS approach and conduct experimental studies in rodent and large animal models to evaluate its efficacy and safety, with the goal of securing an Investigational Device Exemption (IDE) and initiating a preclinical pilot trial in humans. The award supports collaboration with the University of Arizona, which will provide guidance on rodent studies, conduct swine studies, and assist with the IDE approval process.
Generated 1/28/25, 8:18 AM